Clinical Trial Manager
cAMPfield Therapeutics
Clinical Trial Manager
cAMPfield Therapeutics
Develops oral PDE4 inhibitors for IBD
Clinical Trial Manager
Location: Hybrid | Boston, MA
Employment Type: Full‑time
cAMPfield is a clinical-stage biopharmaceutical company focused on developing well-tolerated and highly effective oral medicines, founded and led by industry veterans with success developing therapies for immune-mediated inflammatory diseases, including inflammatory bowel disease (IBD).
About the Role
The Clinical Trial Manager (CTM) is responsible for supporting the day‑to‑day management of clinical studies from startup through closeout. This role is ideal for someone who is energized by cross‑functional collaboration, proactive problem‑solving, and the pace of an emerging biotech. The CTM will oversee CROs, vendors, timelines, budgets, and ensure inspection‑ready execution across all phases of the trial.
Key Responsibilities
Study Planning & Execution
CRO & Vendor Oversight
Clinical Operations Leadership
Data & Quality Oversight
Study Closeout
Qualifications
What We Offer
Develops oral PDE4 inhibitors for IBD
cAMPfield Therapeutics develops oral small-molecule therapies for inflammatory and immunological diseases. Its lead program, prifemilast, is an oral PDE4 inhibitor being developed for inflammatory bowel disease (IBD), including ulcerative colitis. The drug’s mechanism targets PDE4 to reduce inflammation, and prifemilast has shown efficacy in Phase 2 studies for ulcerative colitis. The company focuses on in-licensing assets with potential to transform patient care and aims to establish prifemilast as a preferred IBD treatment with a favorable safety profile. Global rights to prifemilast (also known as HPP737) were acquired from vTv Therapeutics and Newsoara Biopharma. cAMPfield recently launched with a $180 million Series A led by top-tier investors, signaling growth plans and potential partnerships. The company’s goal is to bring a best-in-class oral PDE4 inhibitor to patients and pursue collaborations that advance its clinical programs.
Explore more opportunities at cAMPfield Therapeutics